ROVE-HOTELS
15.12.2020 12:58:15 CET | Business Wire | Press release
Introducing Rove La Mer Beach, a brand-new hotel on the sunny shores of Dubai’s iconic La Mer beachfront, where the surf meets the city. Guided by Dubai Tourism’s vision to offer global travellers customisable experiences suitable for every type of visitor, Rove La Mer Beach gives Rovers (guests) the perfect excuse to soak in the sun, sand and pristine beach waters, explore trendy restaurants, and enjoy an affordable beachside stay. Centrally located, only a 10-minute drive from City Walk and Downtown Dubai.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201215005579/en/
“ Rove La Mer Beach is Rove Hotels’ first beachfront hotel and an exciting step in the brand’s journey. As we add more and more convenient locations to our ever-growing collection of well-connected hotels, we continue to find new ways to engage the modern traveller with a diverse array of enriching experiences. By bringing fun, affordable and fuss-free hospitality to La Mer, Rove aims to redefine people’s expectations of what a beachfront hotel is supposed to be and make them accessible to a wider range of travellers ,” says Paul Bridger of Rove Hotels.
Cool, Comfortable Stays
An ideal escape to the seascape for a cool, comfortable, relaxing stay, Rove La Mer Beach offers choices of two Rover Room types, one with skyline views, the other with sea views, along with interconnecting room options. Each room is fully equipped with all essentials, plus a Juliet balcony to admire breath-taking views of the city and sea.
Dubai’s Eclectic Beachfront, Right at the Doorstep
Featuring a waterpark, cinema, inflatable playgrounds, water-sports, boutique stores, 50+ gourmet restaurants, lounges, outdoor sports facilities, and more, Rove La Mer Beach is located on the beachfront of one of Dubai’s most exciting outdoor destinations, offering plenty of activities for solo adventurers and families.
Relaxed Beachside Experiences
Rove La Mer Beach features a variety of food and beverage options, both indoors and outdoors at the hotel terrace, overlooking the beach. With refreshing bevvies at the Drink Truck, vibrant music, drinks at the Beach Bar, and all-day dining at The Daily – there’s something for everyone.
Special Opening Offer
Book a stay at Rove La Mer Beach through rovehotels.com from $100++ per night, including a sea-view upgrade, late check-out and 30% off food and drinks (until 31st January 2021).
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20201215005579/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom